Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease

Publisher： Karger

E-ISSN： 1421-9670|45|5|380-388

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.45, Iss.5, 2017-03, pp. : 380-388

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dyslipidemia in Patients with Chronic and End-Stage Kidney Disease

By  

Cardiorenal Medicine, Vol. 3, Iss. 3, 2013-07 ,pp. : 165-177

Karger

Access to resources Recommend Favorite

Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients

By  

American Journal of Nephrology, Vol. 45, Iss. 3, 2017-01 ,pp. : 187-199

Karger

Access to resources Recommend Favorite

Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease

By  

American Journal of Nephrology, Vol. 44, Iss. 4, 2016-09 ,pp. : 316-325

Karger

Access to resources Recommend Favorite

Impact of Chronic Kidney Disease and Anemia on Physical Function in Patients with Chronic Heart Failure

By  

Cardiorenal Medicine, Vol. 4, Iss. 2, 2014-04 ,pp. : 73-81

Karger

Access to resources Recommend Favorite

Anemia in Chronic Kidney Disease and Congestive Heart Failure

By  

Blood Purification, Vol. 21, Iss. 1, 2003-01 ,pp. : 124-130

Karger

Access to resources Recommend Favorite